Bridging Cancer Biology with the Clinic: Relative Expression of a GRHL2-Mediated Gene-Set Pair Predicts Breast Cancer Metastasis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yang, Xinan ^a   Vasudevan, Prabhakaran ^a   Parekh, Vishwas ^a   Penev, Aleks ^a   Cunningham, John M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; NERVE CELL ADHESION MOLECULE; TRANSFORMING GROWTH FACTOR BETA3; UVOMORULIN;

ACTA2 GENE; ADULT; ANIMAL CELL; ARTICLE; BREAST METASTASIS; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CITED2 GENE; CLINICAL INDICATOR; CTNNA1 GENE; CTNNA3 GENE; CTNNB1 GENE; E CADHERIN GENE; FN1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GRAINY HEAD LIKE 2 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; MKI67 GENE; MOLECULAR PATHOLOGY; MOUSE; N CADHERIN GENE; NONHUMAN; ONCOGENE; PREDICTION; RHOA GENE; TGFB3 GENE; TUMOR VOLUME; UPREGULATION;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM METASTASIS; NUCLEOTIDE MOTIFS; POSITION-SPECIFIC SCORING MATRICES; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874184109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056195     Document Type: Article

References (48)

1. Ravnan MC, Ravnan SL, Walberg MP (2011) Metastatic breast cancer: A review of current and novel pharmacotherapy. Formulary.
2. Buness A, Kuner R, Ruschhaupt M, Poustka A, Sultmann H, et al. (2007) Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer. Bioinformatics 23: 2273-2280.
3. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, et al. (2003) Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63: 8861-8868.
4. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20.
5. Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, et al. (2010) Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 16: 214-218.
6. Leth-Larsen R, Terp MG, Christensen AG, Elias D, Kuhlwein T, et al. (2012) Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol Med.
7. Venet D, Dumont JE, Detours V, (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240.
8. Thomassen M, Tan Q, Eiriksdottir F, Bak M, Cold S, et al. (2007) Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer. Clin Cancer Res 13: 5355-5360.
9. Massague J, (2007) Sorting out breast-cancer gene signatures. N Engl J Med 356: 294-297.
10. Eddy JA, Sung J, Geman D, Price ND, (2010) Relative expression analysis for molecular cancer diagnosis and prognosis. Technol Cancer Res Treat 9: 149-159.
11. Chopra P, Lee J, Kang J, Lee S, (2010) Improving cancer classification accuracy using gene pairs. PLoS One 5: e14305.
12. De Rienzo A, Dong L, Yeap BY, Jensen RV, Richards WG, et al. (2011) Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 17: 310-316.
13. Magis AT, Earls JC, Ko YH, Eddy JA, Price ND, (2011) Graphics processing unit implementations of relative expression analysis algorithms enable dramatic computational speedup. Bioinformatics 27: 872-873.
14. Cieply B, Riley Pt, Pifer PM, Widmeyer J, Addison JB, et al. (2012) Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer Res 72: 2440-2453.
15. van Vliet MH, Reyal F, Horlings HM, van de Vijver MJ, Reinders MJ, et al. (2008) Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability. BMC Genomics 9: 375.
16. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, et al. (2007) Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25: 1239-1246.
17. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555.
18. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-964.
19. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13: 3207-3214.
20. Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, et al. (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A 104: 6740-6745.
21. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
22. Pulaski BA, Ostrand-Rosenberg S (2001) Mouse 4T1 breast tumor model. Curr Protoc Immunol Chapter 20: Unit 20 22.
23. Espinosa-Neira R, Mejia-Rangel J, Cortes-Reynosa P, Salazar EP, (2011) Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A. Int J Biochem Cell Biol 43: 1782-1791.
24. Moleirinho S, Chang N, Sims AH, Tilston-Lunel AM, Angus L, et al. (2012) KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals. Oncogene.
25. Xiang X, Zhuang X, Ju S, Zhang S, Jiang H, et al. (2011) miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene 30: 3440-3453.
26. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, et al. (2012) Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochim Biophys Acta 1826: 297-311.
27. Hazan RB, Qiao R, Keren R, Badano I, Suyama K, (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014: 155-163.
28. Morrogh M, Andrade VP, Giri D, Sakr RA, Paik W, et al. (2012) Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Res Treat 132: 641-652.
29. Meehan M, Melvin A, Gallagher E, Smith J, McGoldrick A, et al. (2007) Alpha-T-catenin (CTNNA3) displays tumour specific monoallelic expression in urothelial carcinoma of the bladder. Genes Chromosomes Cancer 46: 587-593.
30. Fang X, Cai Y, Liu J, Wang Z, Wu Q, et al. (2011) Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30: 4707-4720.
31. Ma J, Zhao QL, Ren H, Liu WC, Xue Y, (2012) [Role of RhoA in hypoxia-induced breast cancer cell VEGF secretion and proliferation, migration and tube formation of HUVECs]. Nan Fang Yi Ke Da Xue Xue Bao 32: 784-788.
32. Yamamoto S, Ibusuki M, Yamamoto Y, Fu P, Fujiwara S, et al. (2012) Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens. Breast Cancer.
33. van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, et al. (2009) CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer. British journal of cancer 101: 1824-1832.
34. Yamashita M, Ogawa T, Zhang X, Hanamura N, Kashikura Y, et al. (2012) Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome. Breast Cancer 19: 170-176.
35. Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, et al. (2010) Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol 177: 387-403.
36. Itoh S, Itoh F, (2012) Implication of TGF-beta as a survival factor during tumour development. J Biochem 151: 559-562.
37. Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, et al. (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68: 5405-5413.
38. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
39. Lipták T (1958) On the combination of independent tests. In: Int MTAMK, editor. 171-196.
40. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009.
41. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
42. Harrell JC, Prat A, Parker JS, Fan C, He X, et al. (2012) Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat 132: 523-535.
43. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006) TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34: D108-110.
44. Pennacchio LA, Rubin EM, (2003) Comparative genomic tools and databases: providing insights into the human genome. J Clin Invest 111: 1099-1106.
45. Aslakson CJ, Miller FR, (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399-1405.
46. Ming T, Cunningham JM (2011) The Grainyhead-Like 2 (Grhl2) Transcription Factor Is Essential For Normal And Malignant Mammary Ontogeny. Chicago Area Undergraduate Research Symposium. Chicago. 30.
47. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
48. Wasserman WW, Sandelin A, (2004) Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 5: 276-287.